Labcorp (NYSE:LH) and Hims & Hers Health (NYSE:HIMS) Head to Head Survey

Hims & Hers Health (NYSE:HIMS) and Labcorp (NYSE:LH) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, dividends, institutional ownership, risk and profitability.

Valuation & Earnings

This table compares Hims & Hers Health and Labcorp”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.58 billion	2.50	$128.37 million	($0.63)	-43.79
Labcorp	$13.95 billion	2.10	$876.50 million	$12.19	29.69

Labcorp has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings for Hims & Hers Health and Labcorp, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1	11	3	0	2.13
Labcorp	0	3	7	1	2.82

Hims & Hers Health presently has a consensus target price of $32.43, indicating a potential upside of 17.55%. Labcorp has a consensus target price of $365.67, indicating a potential upside of 1.02%. Given Hims & Hers Health’s higher possible upside, research analysts clearly believe Hims & Hers Health is more favorable than Labcorp.

Risk and Volatility

Hims & Hers Health has a beta of 2.44, indicating that its stock price is 144% more volatile than the S&P 500. Comparatively, Labcorp has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500.

Profitability

This table compares Hims & Hers Health and Labcorp’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Labcorp	6.88%	17.13%	7.96%

Insider & Institutional Ownership

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 95.9% of Labcorp shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Comparatively, 0.8% of Labcorp shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Labcorp beats Hims & Hers Health on 11 of the 15 factors compared between the two stocks.

About Hims & Hers Health

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

About Labcorp

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.